Clinical Trial Update: A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 double-blind, placebo-controlled trial evaluating whether galantamine improves cognitive dysfunction in individuals with bipolar disorder. The study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED